Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Lipocine (NASDAQ:LPCN)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Lipocine Charts.

Lipocine (NASDAQ:LPCN)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Lipocine Charts.

Lipocine Inc News

Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154
Wednesday 1 May 2024 (18 hours ago) • PR Newswire (US)

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
Thursday 11 April 2024 (3 weeks ago) • PR Newswire (US)

Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
Thursday 28 March 2024 (1 month ago) • PR Newswire (US)

Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154
Monday 25 March 2024 (1 month ago) • PR Newswire (US)

Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Lipocine Announces Financial Results for the Full Year Ended December 31, 2023
Friday 8 March 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Lipocine to Present at 36th Annual Roth Conference
Thursday 7 March 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 13 February 2024 (3 months ago) • Edgar (US Regulatory)

Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154
Wednesday 7 February 2024 (3 months ago) • PR Newswire (US)

More Lipocine Inc News Articles

National Australia Bank

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions